AVIR
Atea Pharmaceuticals Inc
5.10$
-1.2%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 17 | Q1 18 | Q2 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | +35.7% | -8.5% | -45.7% | +485.7% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | +0.0% | +193,775.0% | +75.4% | +1.8% | +91.9% | +49.8% | +8.1% | +34.4% | -48.7% | -99.9% | +35,127.9% | -2.8% | +96.7% | -44.3% | +11.9% | -99.4% | +0.0% | +0.0% | +19,056.7% | -99.5% | +3,207.7% | -29.7% | +1,480.6% | -99.7% | +0.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | +13.3% | -47.8% | -149.6% | – | -122.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +52.4% | -43.2% | +95.7% | -14.7% | +44.7% | -19.1% | +174.9% | +75.4% | +1.8% | +91.9% | +49.8% | +8.1% | +34.4% | -47.3% | -34.8% | -75.3% | +483.9% | +4.6% | 0.0% | +6.6% | +9.8% | +64.3% | -39.7% | -24.6% | -1.9% | +15.2% | +9.1% | +18.8% | +24.7% | -14.0% | -31.6% | – | |
| – | +0.0% | +0.0% | +58.4% | -16.4% | -3.9% | +52.2% | -7.2% | -2.9% | +83.7% | +79.2% | +251.0% | -38.1% | +35.9% | +0.3% | +10.5% | -4.9% | -0.8% | -8.5% | +8.6% | +2.1% | +4.4% | -4.3% | -8.5% | +6.1% | -0.1% | -9.6% | +20.9% | -29.2% | -4.1% | -20.4% | -1.4% | -3.4% | +1.1% | – | |
| – | – | – | – | – | +56.7% | +1.4% | +25.9% | -14.8% | -44.4% | +79.2% | +251.0% | -38.1% | +35.9% | +0.3% | +10.5% | -4.9% | +157.5% | -49.6% | +54.7% | -49.9% | +51.4% | +19.0% | +104.5% | +50.0% | -32.8% | -63.1% | +125.3% | -8.5% | +9.3% | -81.2% | +649.1% | -12.8% | -26.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | +48.5% | -71.7% | -354.9% | – | -134.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +1,002.0% | +305.7% | +27.6% | +14.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | +48.7% | -71.5% | -352.8% | – | -134.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -15.3% | -32.8% | -102.4% | – | -3,294.2% | – | +60.2% | +27.4% | -12.0% | +57.9% | -33.8% | +5.2% | -7.0% | -0.4% | -9.8% | +2.0% | -5.3% | -3,553.1% | – | -52.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | +48.7% | -95.0% | -1,932.0% | – | -135.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | +48.5% | -71.5% | -352.5% | – | -134.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.